🇺🇸 M-M-R II vaccine in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 9

Most-reported reactions

1. Asthenia — 1 report (11.11%)
2. Bladder Distension — 1 report (11.11%)
3. Condition Aggravated — 1 report (11.11%)
4. Dermatitis Herpetiformis — 1 report (11.11%)
5. Dyspnoea — 1 report (11.11%)
6. Fatigue — 1 report (11.11%)
7. Haemoglobin Decreased — 1 report (11.11%)
8. Serum Sickness — 1 report (11.11%)
9. Yellow Skin — 1 report (11.11%)

Source database →

Frequently asked questions

Is M-M-R II vaccine approved in United States?

M-M-R II vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for M-M-R II vaccine in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.